Downregulation of TPX2 significantly reduced the expression levels of Bcl-2, c-Myc, and Cyclin D1, inhibited PI3K/AKT signaling, suppressed cell proliferation, and promoted apoptosis, thus possibly preventing the development and progression of HCC [18]. This evidence concerns the gene TPX2 and hepatocellular carcinoma.